Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
Psoriatic arthritis
•
General Rheumatology
•
Biologics
•
Allergy & Immunology
•
Dermatology
•
Atopic Dermatitis
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
Related Questions
How do you approach managing nausea and GI side effects when initiating methotrexate?
Are there any immunosuppressive agents that have been shown to have utility in concurrent idiopathic anaphylaxis?
Would you continue TNF-inhibitor in a patient with psoriatic arthritis who has had multiple nonmelanoma skin cancers requiring Mohs surgery?
Does the presence of calcified granulomas on chest imaging influence your choice of biologic for treatment of psoriatic arthritis (or rheumatoid arthritis)?
How would you approach management of a patient who develops squamous cell skin cancer while on abatacept?
Are you comfortable with using NSAIDs in a patient on methotrexate for inflammatory arthritis?
How do you approach treatment of a patient with active RA and a history of Lynch Syndrome?
Are there concerns with combining anti-IL5 biologics (mepolizumab or benralizumab) for severe asthma with other biologics for RA (e.g. TNFi)?
How do you approach immunosuppression in patients with a positive Interferon Gamma Release Assay and prior intravesicular BCG treatment for bladder cancer?
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?
